11th International Workshop on Clinical Pharmacology of HIV Therapy, 7-9 April, 2010, Sorrento, Italy


Summary reports from this workshop included below have been selected from a comprehensive report from the Liverpool pharmacology group.

The full report is available in PDF format:

Reports in this issue include:

  • Atazanavir absorption maximised with food
  • Methadone levels reduced moderately by rilpivirine
  • Maraviroc 150mg once-daily achieves target concentrations with atazanavir/ritonavir
  • Raltegravir and unboosted atazanavir
  • Raltegravir dose adjustment not required for patients on dialysis
  • Raltegravir and darunavir pharmacokinetics in liver disease
  • Tenofovir may require closer renal monitoring in older patients
  • Effect of age on atazanavir, darunavir, raltegravir and etravirine
  • TDM targets for raltegravir
  • Impact on billirubin levels when atazanavir is dosed twice-daily

Selected abstracts and presentations from the 2010 workshop are now on the Virology Education website:

Links to other websites are current at date of posting but not maintained.